TY - JOUR
KW - Substance Use Disorders -- Drug Therapy
KW - Homelessness -- Psychosocial Factors
KW - Naltrexone -- Administration and Dosage
KW - Buprenorphine -- Administration and Dosage
KW - Naloxone -- Administration and Dosage
KW - Drug Therapy, Combination
KW - Recurrence -- Risk Factors
KW - Risk Assessment
KW - Human
KW - Secondary Analysis
KW - Communities
KW - United States
KW - Adult
KW - DSM
KW - Inpatients
KW - Patient Admission
KW - Descriptive Statistics
KW - mediation analysis
KW - Patient Compliance
KW - Depression
KW - pain
KW - Confidence Intervals
KW - Treatment Outcomes
AU - Kara E. Rudolph
AU - Iván Díaz
AU - Nima S. Hejazi
AU - Mark J. Laan
AU - Sean X. Luo
AU - Matisyahu Shulman
AU - Aimee Campbell
AU - John Rotrosen
AU - Edward V. Nunes
A1 - 
AD - Department of Epidemiology, Mailman School of Public Health, Columbia University, New York NY,, USA; Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York NY,, USA; Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley CA,, USA; Department of Psychiatry, School of Medicine, Columbia University and New York State Psychiatric Institute, New York NY,, USA; Department of Psychiatry, School of Medicine, New York University, New York NY,, USA
BT - Addiction
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 8
DO - 10.1111/add.15377
IS - 8
JF - Addiction
LA - English
M1 - Journal Article
PY - 2021
SN - 0965-2140
SP - 2094
EP - 2103
EP - 
T1 - Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables
T2 - Addiction
TI - Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables
U1 - Healthcare Disparities; Opioids & Substance Use
U3 - 10.1111/add.15377
UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=151210158&site=ehost-live
VL - 116
VO - 0965-2140
Y1 - 2021
Y2 - 08
ER -